drugset / Trial / NCT06413355
FAPI-74 PET/CT in Adults With Fibrosis
NaSingle-groupOpen-labelDiagnostic
Summary
This protocol is intended as a basket protocol designed to evaluate the use of Fibroblast Activating Protein (FAP) PET/CT in imaging the presence of fibrosis caused by a variety of medical conditions where fibrosis is believed to lead to pathological effects and poor prognosis.
Timeline
- Start
- 2024-07-16
- Primary completion
- 2027-07-30
- Completion
- 2027-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [F-18]-FAPI-74 | Diagnostic / imaging agent | 296 mbq | — |
Indications
No indication recorded.